市場調査レポート

商品コード

1098626

髄膜炎ワクチンの市場規模・シェア・展望・機会 (2022年～2030年)：ワクチン・年齢層・流通経路・国別

Meningitis Vaccines Market, by Vaccine, by Age Group, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: 2022年06月17日 | 発行: Coherent Market Insights

| ページ情報: 英文 359 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 704,925円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,096,550円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,566,500円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.65円

全表示
概要
目次

概要

サンプル依頼リストに入れる

主要企業による製品の上市および承認への注力が予測期間中の世界の髄膜炎ワクチン市場の成長を後押しすると予想されています。

当レポートでは、世界の髄膜炎ワクチンの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、パイプラインの分析、市場規模の推移・予測、各種区分・主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

エジプト
ナイジェリア
モロッコ
インドネシア
バングラデシュ
マレーシア
アラブ首長国連邦
サウジアラビア
パキスタン
トルコ
カザフスタン
ヨルダン
カタール
スーダン
レバノン
ウガンダ
ベナン
カメルーン
ガボン
コートジボワール
ベトナム
シンガポール
メキシコ
アルゼンチン
タイ
フィリピン
ネパール
ミャンマー
その他の地域

第9章競合情勢

GlaxoSmithKline plc.
Sanofi S.A.
Merck & Co., Inc.
Pfizer Inc.
Novartis AG
Walvax Biotechnology Co., Ltd.
Incepta Pharmaceuticals Ltd.
Serum Institute of India Pvt. Ltd.
Vacsera
Zhi Fei Biological
BIO MED
Chengdu Kanghua Biological Products
Bharat Biotech.
LG Chem
Espromed Bio
Panacea Biotec Limited
Sinovac Biotech Co., Ltd.
CanSinoBIO
Eubiologics Co., Ltd.

第10章セクション

Product Code: CMI5042

Meningitis is an inflammation of the tissue layers that surround the brain and spinal cord (meninges) as well as the fluid-filled area between the meninges (subarachnoid space). Meningitis can be caused by bacteria, viruses, fungus, or non-infectious illnesses. Meningitis symptoms include headache, fever, and a stiff neck that makes lowering the chin to the chest difficult or impossible, though infants may not have a stiff neck and symptoms may differ in the elderly and individuals who use immune-suppressing medicines. Vaccination is a safe option to develop immunity against meningitis. Immunization of individuals most at risk of being infected helps to protect the individuals from meningitis, prevents its spread within communities, and eventually benefits the entire population. However, not all causes of meningitis and septicemia are vaccine preventable so being able to recognize the symptoms is important.

Market Dynamics

Key companies in the market are focusing on product launches and approvals for meningitis vaccines which is expected to boost the global meningitis vaccines market growth over the forecast period. For instance, in June 2021, CanSinoBIO, an innovative biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has a trade name: Menphecia. Menphecia delivers protection against infection of Group A and C Neisseria meningitides.

Moreover, in May 2019, the Ministry of Health of Ireland had approved the menACWY vaccine to be administered to thousands of children & adults in Ireland due to rising cases of meningitis that were reported in 2018.

Key features of the study:

This report provides in-depth analysis of the global meningitis vaccines market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc., Sanofi S.A., Merck & Co., Inc., Pfizer Inc., Novartis AG, Walvax Biotechnology Co., Ltd., Incepta Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd., Vacsera, Zhi Fei Biological, BIO MED, Chengdu Kanghua Biological Products, Bharat Biotech., LG Chem, Espromed Bio, Panacea Biotec Limited, Sinovac Biotech Co., Ltd., CanSinoBIO, and Eubiologics Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningitis vaccines market

Detailed Segmentation:

Global Meningitis Vaccines Market, By Vaccine:
- Pneumococcal Conjugate Vaccine
- Pneumococcal Polysaccharide Vaccine
- Meningococcal Vaccine
- Others
Global Meningitis Vaccines Market, By Age Group:
- Infants
- Adults
Global Meningitis Vaccines Market, By Distribution Channel:
- Government
- Private
Global Meningitis Vaccines Market, By Country:
- Egypt
- Nigeria
- Morocco
- Indonesia
- Bangladesh
- Malaysia
- United Arab Emirates
- Saudi Arabia
- Pakistan
- Turkey
- Kazakhstan
- Jordan
- Qatar
- Sudan
- Lebanon
- Uganda
- Benin
- Cameroon
- Gabon
- Cote d'Ivoire
- Vietnam
- Singapore
- Mexico
- Argentina
- Thailand
- Philippines
- Nepal
- Myanmar
- Rest of the World
Company Profiles
- GlaxoSmithKline plc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi S.A.
- Merck & Co., Inc.
- Pfizer Inc.
- Novartis AG
- Walvax Biotechnology Co., Ltd.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd.
- Vacsera
- Zhi Fei Biological
- BIO MED
- Chengdu Kanghua Biological Products
- Bharat Biotech.
- LG Chem
- Espromed Bio
- Panacea Biotec Limited
- Sinovac Biotech Co., Ltd.
- CanSinoBIO
- Eubiologics Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine
- Market Snapshot, By Age Group
- Market Snapshots, By Distribution Channel
- Market Snapshot, By Country
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
PEST Analysis
Epidemiology
Vaccine Development Cycle
Vaccine Types/Technology and Route of Administration
Pricing Analysis
Pipeline Analysis
Brand Comparison Mapping

4. Global Meningitis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis

5. Global Meningitis Vaccines Market, By Vaccine, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Pneumococcal Conjugate Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pneumococcal Polysaccharide Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Meningococcal Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Meningitis Vaccines Market, By Age Group, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Infants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Meningitis Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Government
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Meningitis Vaccines Market, By Country, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Countries, 2018-2030
- Country Trends
Egypt
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Nigeria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Morocco
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Indonesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Bangladesh
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Malaysia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
United Arab Emirates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Saudi Arabia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Pakistan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Turkey
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Kazakhstan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Jordan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Qatar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Sudan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Lebanon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Uganda
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Benin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Cameroon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Gabon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Cote d'Ivoire
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Vietnam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Singapore
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Thailand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Philippines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Nepal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Myanmar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Rest of the World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)

9. Competitive Landscape

GlaxoSmithKline plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Walvax Biotechnology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Incepta Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vacsera
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zhi Fei Biological
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BIO MED
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chengdu Kanghua Biological Products
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bharat Biotech.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LG Chem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Espromed Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Panacea Biotec Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sinovac Biotech Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CanSinoBIO
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eubiologics Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

髄膜炎ワクチンの市場規模・シェア・展望・機会 (2022年～2030年)：ワクチン・年齢層・流通経路・国別

Meningitis Vaccines Market, by Vaccine, by Age Group, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界の髄膜炎ワクチン市場：COVID-19の影響

第5章世界の髄膜炎ワクチン市場：ワクチン別

第6章世界の髄膜炎ワクチン市場：年齢層別

第7章世界の髄膜炎ワクチン市場：流通経路別

第8章世界の髄膜炎ワクチン市場：国別

第9章競合情勢

第10章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Meningitis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Meningitis Vaccines Market, By Vaccine, 2017 - 2030, (US$ Million)

6. Global Meningitis Vaccines Market, By Age Group, 2017 - 2030, (US$ Million)

7. Global Meningitis Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Million)

8. Global Meningitis Vaccines Market, By Country, 2017 - 2030, (US$ Million)

9. Competitive Landscape

10. Section

髄膜炎ワクチンの市場規模・シェア・展望・機会 (2022年～2030年)：ワクチン・年齢層・流通経路・国別

Meningitis Vaccines Market, by Vaccine, by Age Group, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

第4章 世界の髄膜炎ワクチン市場：COVID-19の影響

第5章 世界の髄膜炎ワクチン市場：ワクチン別

第6章 世界の髄膜炎ワクチン市場：年齢層別

第7章 世界の髄膜炎ワクチン市場：流通経路別

第8章 世界の髄膜炎ワクチン市場：国別

第9章 競合情勢

第10章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Meningitis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Meningitis Vaccines Market, By Vaccine, 2017 - 2030, (US$ Million)

6. Global Meningitis Vaccines Market, By Age Group, 2017 - 2030, (US$ Million)

7. Global Meningitis Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Million)

8. Global Meningitis Vaccines Market, By Country, 2017 - 2030, (US$ Million)

9. Competitive Landscape

10. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界の髄膜炎ワクチン市場：COVID-19の影響

第5章世界の髄膜炎ワクチン市場：ワクチン別

第6章世界の髄膜炎ワクチン市場：年齢層別

第7章世界の髄膜炎ワクチン市場：流通経路別

第8章世界の髄膜炎ワクチン市場：国別

第9章競合情勢

第10章セクション